Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma.
Blood Adv
; 6(3): 1025-1037, 2022 02 08.
Article
in En
| MEDLINE
| ID: mdl-34941996
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Non-Hodgkin
/
Lymphoma, B-Cell
/
Antibodies, Bispecific
Type of study:
Guideline
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Blood Adv
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: